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ABSTRACT 
Context: Osteoarthritis (OA) is a common cause of chronic low back pain (CLBP) and can 
be managed with the use of drug therapy and physiotherapy. Homeopathic remedies may 
assist in the management of OA; however, research that supports their effectiveness is 
limited. 
Objectives: The study aimed to investigate the efficacy of a homeopathic complex in 
combination with physiotherapy in the treatment of CLBP due to OA.  
Design: The study was a six-week, randomized, double-blind, placebo-controlled pilot. 
Setting: The study took place in a private physiotherapy practice in Gauteng, South Africa.  
Participants: The participants were 30 males and females, aged 45-75 years, who were 
receiving physiotherapy treatment for OA of the lumbar spine from a therapist in private 
practice. 
Interventions: The intervention and control groups both received standard physiotherapy 
treatment—massage, thermal therapy, and joint mobilization—every 2 weeks. In addition, the 
treatment group received a homeopathic complex—6cH each of Arnica montana, Bryonia 
alba, Causticum, Kalmia latifolia, Rhus toxicodendron, and Calcarea fluorica. The control 
group a received a placebo. 
Outcome measures: The primary measure was a visual analogue scale (VAS) for pain. 
Secondary outcome measures included the Oswestry Disability Index (ODI), an evaluation of 
each patient’s range of motion (ROM) of the lumbar spine, and a determination of each 
patient’s need for pain medication.  
2 
 
Results: Intergroup analysis revealed that the treatment group significantly outperformed the 
control group with regard to pain, daily functioning, and ROM. No difference existed 
between the groups, however, in the need for conventional pain medication.  
Conclusions: The study was too small to be conclusive, but results suggest that the 
homeopathic complex, together with physiotherapy, can improve symptoms associated with 
chronic low back pain due to OA significantly.  
 
Keywords: Physiotherapy, homeopathy, homeopathic complex, chronic low back pain, 
osteoarthritis 
 
 
Osteoarthritis (OA) is the most common cause of disability in older adults and affects 
approximately 9.6% of men and 18% of women worldwide over the age of 60 years.1 
Chronic low back pain (CLBP) resulting from spinal OA has a significant impact on the 
quality of life of sufferers, with the majority requiring ongoing rehabilitation and pain 
management; that treatment in turn places a large burden on the healthcare system.2-4 
Physiotherapy may play a beneficial role in the management of CLBP. Due to the 
diversity of treatments and the lack of randomized control trials (RCTs) on the effectiveness 
of the treatment modalities, however, it is normally used in conjunction with drug therapy.5,6 
While drug therapy shows evidence of short-term effectiveness for CLBP, it is unfortunately 
also associated with numerous adverse effects. Insufficient evidence is available to identify a 
medication that offers a clear, overall, net advantage because of the complex balance between 
benefits and harms.7  
Studies have shown a proclivity among patients with arthritis to seek out 
complementary and alternative (CAM) treatments. Research indicates that 80%-90% of 
arthritis sufferers, in some instances, make use of some form of CAM for the treatment of 
their symptoms.8-10  
Homeopathy is a complementary treatment modality that makes use of highly dilute 
remedies, usually from natural sources.11 It has been proposed that homeopathic remedies 
restore homeostatic functioning by modulating the biological systems within the body rather 
than by exerting direct pharmacological effects.12 Homeopathic medicines are prepared 
through a process of sequential dilution and succussion (vigorous shaking). Centesimal 
potencies (c) are diluted in a 1:100 ratio, and use of the term 6cH implies that the centesimal 
remedy has undergone serial dilution six times at 1:100.13   
Limited evidence exists regarding the efficacy of homeopathic remedies for back 
pain. With regard to CLBP, a multicenter observational study has shown that individualized 
homeopathic treatment can improve quality of life and provided symptomatic relief to 
sufferers.14 One RCT showed the efficacy of a homeopathic complex in the treatment of 
CLBP,15 while another randomized, partly double-blind trial on the efficacy of the 
combination of 2 injectable homeopathic complexes found that they were not superior to a 
placebo.16 A double-blind comparative study investigated the efficacy of a topical 
homeopathic complex in the treatment of acute low back pain and found it to be safer than 
and as effective as a capsicum-based product.17 Homeopathy may potentially offer an 
alternative to drug therapy for CLBP patients who are undergoing physiotherapy treatments; 
however, further investigation is needed. 
 
METHODS 
  The study was a six-week, randomized, double-blind, placebo-controlled pilot. The 
aim of the study was to investigate the efficacy of a homoeopathic complex that was 
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combined with physiotherapy, the intervention group, in comparison to that of physiotherapy 
combined with a placebo, the control group, in the treatment of CLBP due to OA.  
 
Participants 
The study took place at a private physiotherapy practice in Soshanguve, Gauteng, 
South Africa. Forty patients, both males and females, who were receiving physiotherapy 
treatment for OA of the lumbar spine at the physiotherapy practice, were recruited by means 
of purposive sampling via a poster advertisement that was placed in the physiotherapist’s 
private practice. Patients were included if they: (1) were aged 45-75 years; (2) had had 
symptomatic CLBP due to OA for more than 3 months, as diagnosed by a healthcare 
practitioner; (3) experienced symptoms of OA, such as pain and decreased range of motion, 
as subjectively reported and by physical examination; and (4) were receiving physiotherapy 
treatment from the identified physiotherapist.  
Participants were excluded according to the following criteria: (1) were receiving any 
form of therapy other than physiotherapy; (2) had presented with acute LBP with the duration 
of 3 months or less; or (3) were suffering from CLBP as a result of disc herniation, 
compression fracture, lumbar spinal stenosis, or other spondylathropathy. 
Individuals who responded to the poster advertisement were provided with an 
information form pertaining to the study, and after they had agreed to participate, were 
requested to sign a consent form. Participants attended an initial consultation where they 
underwent a physical-screening examination by a member of the research team. 
The current study was given clearance by the Higher Degrees Committee 
(HDC05/02-10) and the Academic Ethics Committee (AEC05/02-10) of the Faculty of 
Health Sciences at the University of Johannesburg (UJ). Both committees report to the 
National Health Research Ethics Council in South Africa. All participants were assured of 
privacy, confidentiality, and anonymity, with the right to withdraw from the study at any 
time.  
 
Procedures 
Over the six-week period of the study, both the intervention and control groups 
received standard physiotherapy treatment from the identified physiotherapist. In addition, 
participants received either a placebo or the homeopathic complex. Consultations with the 
therapist occurred at baseline (week 0) and at the end of weeks 2, 4, and 6. During each 
consultation, participants completed the Oswestry Disability Index (ODI), received a lumbar-
spine range of motion (ROM) test using an attraction-tape measurement, and underwent a 
physical examination in which they rated lumbar pain, both with and without palpation, using 
a visual analogue scale (VAS). Participants were also requested to record the amount of pain 
medication that they took over the study’s period. 
Participants meeting the inclusion criteria were randomly allocated to the intervention 
or the control group. The medication bottles used in the study, containing either a 
homeopathic remedy or a placebo, were numbered and randomized by an independent 
individual using a simple randomization method. Participants selected a pre-numbered bottle, 
thereby allocating themselves randomly to one of the groups. 
The researcher and participants were blinded and were unaware of which bottles 
contained the complex or the placebo, ensuring allocation concealment and preventing 
selection bias.  
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Intervention 
Physiotherapy treatment. All participants underwent a 30-minute session once every 
2 weeks that consisted of lower-back classic massage, mobilization of lumbar joints, and the 
application of a heat pack.  
Homeopathic complex and placebo. The treatment group received the homeopathic 
complex, and the control group received unmedicated lactose tablets that looked and tasted 
the same as the complex. Participants in both groups were instructed to take 2 tablets, 
dissolved under the tongue, 20 minutes before meals, twice daily for the study’s six-week 
period. Overall each participant received 168 tablets; 56 tablets were issued fortnightly to 
assess each participant’s compliance in taking his or her medicine.  
The homoeopathic complex consisted of 6 remedies clinically indicated for the 
treatment of LBP. The tablet contained 6cH each of Arnica montana, Bryonia alba, 
Causticum, Kalmia latifolia, Rhus toxicodendron, and Calcarea fluorica. The remedies were 
manufactured by CoMed (Pretoria, Gauteng, South Africa), a homoeopathic laboratory that 
employs the good manufacturing procedures and quality control that forms the basis for 
quality assurance. The complex was compounded at UJ’s homoeopathic clinic by a qualified 
dispenser.  
 
Outcome Measures 
A pain score that was determined using a visual analogue scale (VAS) was the 
primary outcome measure. The Oswestry Disability Index (ODI), a lumbar-spine range of 
motion (ROM) test, and a determination of the amount of pain medication needed were 
employed as secondary outcome measures. 
VAS. The VAS for pain is an established and validated tool that is used in 
determining the subjective level of pain of an individual.18 The VAS scale used in the current 
study consisted of an 11-point grading scale where 0=no pain and 10=worst pain. 
ODI. The ODI is a valid tool for measuring a patient’s functional disability and is 
considered the gold standard of tests of outcomes related to low back pain. Each section is 
rated on a six-point scale (0-5), with 0 representing no limitation and 5 representing a 
maximal limitation. The total maximum score is 50, which is doubled to create a score out of 
100, which is then interpreted as a percentage of patient-perceived disability; ie, the higher 
the score, the greater the disability.19  
ROM. ROM is routinely measured in patients with low back pain to determine the 
functional limits of the spine. The attraction-tape measurement is a standard approach that 
involves the use of a tape measure, placed directly over the lumbar spine while the patient 
bends as far as they can. A 0-cm mark is represented by the spinal intersection of a horizontal 
line drawn between the left and right posterior, superior iliac spines. From that point, a 
second mark is placed 10 cm superior to the first mark, the lumbar flexion reference, and a 
third mark is placed 5 cm inferior to the first mark, the lumbar extension reference. The 
method has demonstrated test reliability and can differentiate a patient with a normal spine 
from those with significantly limiting LBP.20  
 
Statistical Analysis 
In the context of the current, small pilot study, the research team felt that a total of 30 
participants would be sufficient, because 30 was the minimum number of participants needed 
to ensure adequate statistical power to determine valid scientific effects.21 
Data was processed statistically using SPSS software, version 18.0; SPSS (Carey, NC, 
USA). The Shapiro Wilk test was applied, which showed an abnormal distribution of data, 
and therefore, nonparametric tests were chosen for the analysis. The Friedman and Wilcoxon 
Signed Ranks Tests were used for intragroup analysis, and the Mann-Whitney U test and 
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Independent Samples t-test were used for intergroup analysis. For the purpose of the study, 
the p-values, at a 95% confidence interval, were interpreted as follows: p<0.05 was 
statistically significant. For the Wilcoxon Test, the Bonferroni adjustment was applied to 
correct for multiple comparisons, and therefore, p<0.016 was statistically significant. 
 
RESULTS 
Figure 1 shows the consort flow diagram; 40 volunteers were assessed for eligibility 
and 30 (75%) met the inclusion criteria. All 30 participants completed the study. Fifteen 
participants were in the control group, receiving physiotherapy + placebo, and 15 were in the 
treatment group, receiving physiotherapy + homeopathic complex. Table 1 displays the 
demographics and baseline characteristics of the participants. Both groups exhibited a similar 
age and gender distribution and mean values for pain and functional disability as well as 
ROM. The treatment group had a slightly higher use of pain medication compared to the 
control group.  
>>Insert Figure 1<< 
>>Insert Table 1<< 
 
VAS Without Palpation 
Intergroup analysis. No significant differences existed between the 2 groups at the 
first and second consultations, with p=0.547 and p=0.516, respectively. Significant 
differences, however, did occur in favor of the treatment group at the third and fourth 
consultations. 
 Intragroup analysis. The difference in median pain scores, over time, was 3 for the 
treatment group and 2 for the control group; therefore, the trend of improvement was greater 
for the treatment group (Figure 2). Both groups demonstrated a statistically significant 
improvement over time, from baseline to the end of the study, with the treatment group’s 
results at p<0.001 [χ2 (3, n=15)=42.064] as opposed to the control group’s at p=0.002 [χ2 (3, 
n=15) = 14.831]. Subsequent analysis indicated that the improvement occurred consistently 
over the study’s period for both groups (Table 2). 
>>Insert Figure 2<< 
>>Insert Table 2<< 
 
VAS With Palpation 
Intergroup analysis. Statistically significant differences existed between groups in 
favor of the treatment group at each consultation: (1) week 0, p=0.026; (2) week 2, p=0.002; 
(3) week 4, p<0.001; and (4) week 6, p<0.001 (U=32.500, z=-3.380).  
Intragroup analysis. The difference in median pain scores, over time, was 4 for the 
treatment group and only 2 for the control group (Figure 3). Both groups demonstrated a 
statistically significant improvement over time, from baseline to the end of the study (1) the 
treatment group, with p<0.001 [χ2 (3, n=15) = 41.596]; and (2) the control group, with 
p<0.001 [χ2 (3, n=5) = 23.974]. Subsequent analysis indicates that participants in the 
treatment group experienced significant pain relief consistently over the study’s period 
whereas the control group showed significant improvement only at week 4 (Table 2). 
>>Insert Figure 3<< 
 
ODI 
Intergroup analysis. No statistically significant differences existed between the 2 
groups at the first and second consultations, with p=0.835 and p=0.052, respectively. A 
significant difference occurred, however, in the level of function between the groups in favor 
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of the treatment group at both the third and fourth consultations, with p<0.001 (U=13.000, 
z=-4.144) and p<0.001 (U=10.000, z=-4.262), respectively. 
Intragroup analysis. Figure 4 shows that a reduction in the median values occurred 
for both the treatment (12%) and control (4%) groups, with statistically significant decreases 
in functional disability found over time: (1) the treatment group, with p<0.001 [χ2 (3, n=15) 
= 44.718] and (2) the control group, with p<0.001 [χ2 (3, n=15) = 33.622]. That improvement 
occurred consistently over the study’s period as measured at each consultation (Table 2). 
>>Insert Figure 4<< 
 
ROM: Extension 
Intergroup analysis. No statistically significant differences occurred between the 2 
groups at the first, second, and third consultations, with p=0.484, p=0.148, p=0.080, 
respectively. However, a significant difference existed in favor of the treatment group at the 
fourth consultation, with p=0.021 (U=61.500, z=-2.311).  
Intragroup analysis. The analysis showed that a statistically significant improvement 
in extension occurred over the study’s period for the treatment group, which showed a 2-cm 
increase in the median, with p<0.001 [χ2 (3, n=15) = 34.964], but not for the control group, 
which showed a 1-cm increase in the median, with p=0.051 [χ2 (3, n=15) = 7.787] (Figure 5). 
Subsequent tests indicated that the improvement for the treatment group occurred 
consistently over each consultation (Table 2).  
>>Insert Figure 5<< 
 
ROM: Flexion 
Intergroup analysis. No statistically significant differences existed between the 2 
groups at the first and second consultations, with p=0.899 and p= 0.200, respectively. 
However, significant differences in flexion occurred in favor of the treatment group at the 
third and fourth consultations, with p=0.041 (U=63.000, z=-2.122) and p=0.002 (U=39.500, 
z=-3.121), respectively.  
Intragroup analysis. A statistically significant improvement in flexion occurred over 
time, from baseline to the end of the study, for the treatment group, which showed a 2-cm 
increase in the median, with p<0.001 [χ2 (3, n=15) = 39.046], and for the control group, 
which showed a 1-cm increase in the median, with a p=0.049 [χ2 (3, n=15) = 7.838] (Figure 
6). That improvement occurred consistently at each consultation for the treatment group but 
only from the fourth consultation for the control group (Table 2). 
>>Insert Figure 6<< 
 
Pain Medication 
Intergroup analysis. No statistically significant differences were found between the 
2 groups at week 0, with p=0.53; week 2, with p=0.533; week 4, with p=0.934; or week 6, 
with p=0.531), indicating that neither group outperformed the other. 
Intragroup analysis. Participants in the treatment group initially took twice as much 
pain medication, at 40 tablets per week, than the control group, at 20 tablets per week. 
Participants in the control group recorded use of a fairly consistent quantity of pain 
medication during the study while the treatment group had a vast reduction in the amount of 
pain medication that they needed by week 6, at 10 tablets per week (Figure 7). That reduction 
was statistically significant for both the treatment group, with p<0.001 [χ2 (3, n=15) = 
38.774], and the control group, with p=0.007 [χ2 (3, n=15) = 12.027]. For the treatment 
group, that improvement was evident within the first 2 weeks of the study, whereas for the 
control group, the change occurred only at week 4 (Table 2). The 2 groups were not initially 
matched for the variable; that fact could have had an impact on the results. 
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>>Insert Figure 7<< 
 
DISCUSSION 
The current pilot study aimed to investigate the efficacy of a homeopathic complex in 
combination with physiotherapy in comparison to physiotherapy alone in the treatment of 
CLBP due to OA. The results showed that participants in both the intervention group 
receiving physiotherapy and the homeopathic complex and the control group receiving 
physiotherapy and a placebo, had significant improvements over the six-week period in pain, 
functional ability, and range of motion as well as a consequent reduction in use of 
conventional pain medication. The treatment group, however, consistently showed greater 
improvements, and on average, outperformed the control group by the fourth week of the 
study. While physiotherapy alone provided benefits to OA patients with CLBP, the current 
study’s results indicate that the addition of the homeopathic complex provided even greater 
symptom improvement.  
Physiotherapy is often advocated for patients with CLBP as an initial form of 
conservative pain management and has been shown to provide significant short-term 
improvements in symptoms.6,22 The physiotherapeutic techniques used in the current study 
included classical massage, joint mobilization, and thermal therapy.23 While state that spinal 
manipulation provides moderately superior results over a control therapy in the treatment of 
LBP, classical massage and thermotherapy, when used on their own, do not demonstrate 
efficacy.5 With regard to CLBP due to OA, physiotherapy is traditionally used in 
combination with drug therapy. Drugs such as paracetamol, acetaminophen, nonsteroidal 
anti-inflammatories (NSAIDs) and intra-articular corticosteroid injections are commonly 
prescribed.  
Those drugs provide temporary palliation of symptoms but are unfortunately 
associated with numerous adverse effects, particularly NSAIDs, which are related to an 
increased incidence of   gastrointestinal complications. 24,25  Some NSAIDs have been linked 
to increased risk of death and morbidity in patients with cardiovascular disease.26 Participants 
in the current study were not asked to discontinue their conventional drugs; however, the 
frequency of use was recorded daily. The type of medication used, however, was not 
standardized, and that fact could have had an impact on the results. 
Homeopathy is one of the most frequently sought out complementary modalities by 
patients with rheumatic diseases.27 Homeopathy has a wide range of remedies that may be 
useful in the management of OA symptoms28 and potentially provide an alternative treatment 
to drug therapy. A 12-month, observational, cohort study conducted in France found that 
patients with musculoskeletal disease who consulted homeopathic physicians tended to use 
fewer NSAIDs than those who used conventional medicine alone, thereby reducing NSAID-
related adverse events.29 In one study comparing the efficacy of homeopathy with 
standardized physiotherapy in the treatment of CLBP, the homeopathy group reported a 
significant improvement in daily functioning, and the treatment was generally well-
tolerated.30  
Homeopathic remedies are believed to stimulate physiological responses in the body 
without always being pharmacologically detectable themselves. Potentized remedies, 
therefore, appear to demonstrate no toxicity or addictive properties.31 Also, due to their high 
amount of dilution, homeopathic remedies are considered unlikely to cause drug interactions.  
High dilutions do not, however, equate to medicinal inactivity, and very high dilutions 
have demonstrated effects in humans, plants, animals, cell-cultures, and individual cells.13,32-
34 For example, one study that examined the modulating effect on induced arthritis in rats of 
Rhus toxicodendron in various potencies/dilutions from low to high, found that the remedy in 
all potencies showed anti-arthritic activity.35  
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The remedies chosen for the currently used complex are all clinically indicated for 
CLBP. The choice of potency in the current study, a 6cH, is considered a relatively low 
potency or dilution, which is recommended when treating a chronic, physical pathology36; 
however, investigation using other potencies is warranted. 
No severe side effects were reported in the current study; however, 5 participants in 
the treatment group did report an incident of mild abdominal cramping and diarrhea on the 
first day of treatment that lasted for no longer than 24 hours. Thereafter, those participants 
reported an improvement of their CLBP pain. That side effect was an unexpected finding, and 
it did not occur in any of the control participants. The highly diluted nature of the remedies 
used in the current study precluded the issue being the result of toxicity. According to De 
Schepper,36 after the commencement of homeopathic treatment, minor eliminations from the 
body such as diarrhea, followed by an improvement in the patient’s existing symptoms, is 
evidence of the healing process and is part of the body’s healing response known as Herings 
law of cure.37 Adverse effects in homeopathic treatment, if they do occur, are typically mild 
and transient.11  
 
Limitations of the study 
An important limitation of the study resulted from and conducting the study from a 
single physiotherapy practice. Future research should look at conducting a broader study.  
The most important limitations of the study were the small sample size and the short 
duration of the study. A longer treatment period would help assess whether or not the trend of 
improvement would continue over time. 
 
CONCLUSIONS 
The current randomized, double-blind, placebo-controlled pilot study aimed to 
determine the efficacy of the combination of homeopathy and physiotherapy in the treatment 
of CLBP due to OA. The primary outcome measure was a determination of changes in pain, 
as determined by a VAS. Results showed that the treatment group significantly outperformed 
the control group with regard to reductions in pain and improvements in daily functioning 
and range of motion. No statistically significant differences occurred, however, between the 
groups in the need for conventional pain medication. Based on those results, the 2 treatment 
modalities used in combination may provide symptomatic relief for OA sufferers with CLBP; 
however, further large-scale studies of longer duration are warranted to verify the findings. 
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